Antibody against the CSF-1R

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9221912
APP PUB NO 20140057972A1
SERIAL NO

13932285

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides antibodies specific for the CSF-1R, compositions comprising said antibodies and methods of treatment using such compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRANSGENE S AILLKIRCH GRAFFENSTADEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Geist, Michel Brumath, FR 9 194
Grellier, Benoît Strasbourg, FR 7 132
Haegel, Hélène Strasbourg, FR 7 142
Thioudellet, Christine Strasbourg, FR 8 179

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 29, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00